Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display.
暂无分享,去创建一个
[1] E. Ruoslahti,et al. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[2] H. Hoogenboom. Overview of antibody phage-display technology and its applications. , 2002, Methods in molecular biology.
[3] Hélder A Santos,et al. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. , 2013, Biomaterials.
[4] Erkki Ruoslahti,et al. A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[5] P. Laakkonen,et al. Peptide-based glioma-targeted drug delivery vector gHoPe2. , 2013, Bioconjugate chemistry.
[6] Erkki Ruoslahti,et al. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. , 2003, Cancer cell.
[7] Simon C Watkins,et al. Identification of a Cardiac Specific Protein Transduction Domain by In Vivo Biopanning Using a M13 Phage Peptide Display Library in Mice , 2010, PloS one.
[8] Heikki Joensuu,et al. Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors , 2014, Molecular Cancer Therapeutics.
[9] Erkki Ruoslahti,et al. αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.
[10] Ü. Langel,et al. A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] Erkki Ruoslahti,et al. A tumor-homing peptide with a targeting specificity related to lymphatic vessels , 2002, Nature Medicine.
[12] P. Robbins,et al. Identification and characterization of tissue-specific protein transduction domains using peptide phage display. , 2011, Methods in molecular biology.
[13] Ü. Langel,et al. Assessing the delivery efficacy and internalization route of cell-penetrating peptides , 2007, Nature Protocols.
[14] Erkki Ruoslahti,et al. Targeting the prostate for destruction through a vascular address , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] R Pasqualini,et al. NG2 proteoglycan-binding peptides target tumor neovasculature. , 1999, Cancer research.
[16] Erkki Ruoslahti,et al. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Ruoslahti,et al. Molecular Profiling of Heart Endothelial Cells , 2005, Circulation.
[18] Yan Li,et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy , 2004, Nature.
[19] E. Ruoslahti,et al. Peptide Targeting of Tumor Lymph Vessels , 2008, Annals of the New York Academy of Sciences.
[20] E. Ruoslahti. Specialization of tumour vasculature , 2002, Nature Reviews Cancer.
[21] K. Kinzler,et al. Genes expressed in human tumor endothelium. , 2000, Science.
[22] S. Dowdy,et al. TAT transduction: the molecular mechanism and therapeutic prospects. , 2007, Trends in molecular medicine.
[23] D. Hanahan,et al. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. , 2003, Cancer cell.
[24] Erkki Ruoslahti,et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. , 2009, Cancer cell.
[25] R Pasqualini,et al. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. , 1998, The Journal of clinical investigation.
[26] P. Lundin,et al. Distinct uptake routes of cell-penetrating peptide conjugates. , 2008, Bioconjugate chemistry.
[27] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[28] E. Ruoslahti,et al. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.
[29] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[30] Erkki Ruoslahti,et al. Organ targeting In vivo using phage display peptide libraries , 1996, Nature.